News Roundup

  • Vizient Announces Expansion of Novaplus Enhanced Supply in Med/Surg, Pharmacy: Vizient announced it has expanded Novaplus® Enhanced Supply to include three new medical/surgical categories and an antidotes category for pharmaceutical supplies. The new med/surg categories are durable medical equipment, sterile inhalation water and non-invasive ventilation. The antidotes category has 60 unique drugs, with 14 products already added to the program. Vizient Newsroom
  • Vizient Joins Healthcare Industry Resilience Collaborative: As the nation’s healthcare providers continue to be impacted by supply chain disruptions, Vizient announced that it has joined the Healthcare Industry Resilience Collaborative, a nonprofit healthcare supply chain association that champions standards and best practices in supply chain resiliency. The provider-led, supplier-supported organization brings together key stakeholders across healthcare to align on common solutions to supply disruptions that impact patient care. Vizient Newsroom
  • Vizient and RISCS Announce Pilot Program to Improve Pharmaceutical Supply Chain Resilience: Vizient and RISCS, Inc., in early May announced a joint pilot program aimed at enhancing assurance of pharmaceutical supply. Once implemented, the program will use a rating system to enable the evaluation of critical aspects of a resilient supply chain and provide increased transparency. Vizient Newsroom
  • Exclusivity Creates Challenges in Price, Access for Long-Used Medications: Vizient’s Steven Lucio, principal, pharmacy solutions, and Jenna Stern, senior regulatory affairs and public policy director, delved into the unintended consequences (such as financial challenges and access issues for health systems) of the FDA’s Unapproved Drug Initiative. Pharmaceutical Commerce
  • Vizient Improves Visibility into Domestically Manufactured Supplies: In April, Vizient announced the launch of the Made in the U.S.A. program to enhance supply assurance for member healthcare providers by improving visibility of domestic manufacturing in its contract portfolio. The program identifies products manufactured domestically, providing a way for Vizient members to mitigate against international supply disruptions. Vizient members will be able to quickly identify products made in the U.S. within the Vizient catalog, and eligible suppliers will receive new opportunities to showcase their domestically manufactured products. Vizient Newsroom

Blogs you May Have Missed

 

Published: May 17, 2022